Latest Articles
Bindi Irwin Recalls 10 Years of 'Agonizing Pain' Before Endometriosis Diagnosis: 'I Was Incredibly Unwell' - AOL
Bindi Irwin Recalls 10 Years of 'Agonizing Pain' Before Endometriosis Diagnosis: 'I Was Incredibly Unwell' AOL
Published: Feb. 15, 2025, 5:50 a.m.
Amid uncertainty around federal science funding, CT maintains investment in endometriosis research - Connecticut Public
Amid uncertainty around federal science funding, CT maintains investment in endometriosis research Connecticut Public
Published: Feb. 14, 2025, 10:06 p.m.
Childhood trauma may increase the risk of endometriosis, reveals research - Medical Dialogues
Childhood trauma may increase the risk of endometriosis, reveals research Medical Dialogues
Published: Feb. 14, 2025, 2:45 p.m.
Endometriosis Market estimated at USD 3.10 Billion by 2030 - openPR
Endometriosis Market estimated at USD 3.10 Billion by 2030 openPR
Published: Feb. 14, 2025, 9:23 a.m.
Thomson Fertility Launches Endo Care @ Thomson, a Holistic Centre for Women with Endometriosis - WeirdKaya
Thomson Fertility Launches Endo Care @ Thomson, a Holistic Centre for Women with Endometriosis WeirdKaya
Published: Feb. 14, 2025, 2:34 a.m.
Early Diagnosis Changes Endometriosis Care: Conference 2025 - Endometriosis Foundation of America - The Blossom
Early Diagnosis Changes Endometriosis Care: Conference 2025 Endometriosis Foundation of America - The Blossom
Published: Feb. 13, 2025, 6:57 p.m.
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug - Forbes
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug Forbes
Published: Feb. 13, 2025, 5:04 p.m.
Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug - Forbes
Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug Forbes
Published: Feb. 13, 2025, 5:04 p.m.
Endometriosis Support Supplements - Trend Hunter
Endometriosis Support Supplements Trend Hunter
Published: Feb. 13, 2025, 1:24 p.m.
From Oncology to Endometriosis: Repurposed Cancer Drug in Phase 2 Trials - Oxford Student
From Oncology to Endometriosis: Repurposed Cancer Drug in Phase 2 Trials Oxford Student
Published: Feb. 13, 2025, 10:18 a.m.
Link copied to clipboard!